JP Stock MarketDetailed Quotes

Kaken Pharmaceutical (4521)

Watchlist
  • 4080
  • 00.00%
20min DelayMarket to Open Apr 30 15:30 JST
180.09BMarket Cap11.17P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kaken Pharmaceutical (4521) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
Total revenue
18.26B
3.36%18.87B
30.52%94.04B
0.57%18.25B
-1.29%72.04B
17.36B
-1.28%18.51B
-3.23%18.02B
-0.26%18.15B
-4.01%72.98B
Cost of revenue
9.01B
9.67%9B
5.96%35.5B
1.33%8.2B
0.23%33.51B
8.68B
-2.37%8.38B
0.98%8.36B
-0.77%8.09B
-2.99%33.43B
Gross profit
9.25B
-1.79%9.87B
51.88%58.53B
-0.04%10.05B
-2.57%38.54B
8.68B
-0.34%10.14B
-6.60%9.66B
0.16%10.06B
-4.86%39.56B
Operating expense
8.9B
35.01%9.86B
29.19%37.49B
7.97%7.3B
-8.02%29.02B
8.04B
13.17%6.78B
20.18%7.44B
13.02%6.76B
28.75%31.55B
Staff costs
--1.81B
0.06%1.73B
-0.17%7.11B
-2.97%1.73B
-0.99%7.12B
--1.85B
-1.34%1.76B
-3.57%1.73B
-0.94%1.78B
-2.88%7.19B
Research and development costs
--3.97B
79.52%5.38B
49.29%18.73B
15.31%3B
-20.56%12.54B
--4.04B
39.60%2.76B
36.43%3.14B
28.08%2.6B
87.52%15.79B
Depreciation and amortization
----
----
-14.51%271M
----
8.93%317M
----
----
----
----
12.79%291M
-Depreciation
----
----
-14.51%271M
----
8.93%317M
----
----
----
----
12.79%291M
Other operating expenses
--3.12B
6.65%2.74B
25.97%11.39B
8.15%2.57B
9.18%9.04B
--1.83B
1.30%2.25B
22.65%2.58B
10.50%2.38B
-1.71%8.28B
Operating profit
351M
-99.42%16M
121.06%21.04B
-16.48%2.75B
18.93%9.52B
641M
-19.69%3.36B
-46.54%2.22B
-18.80%3.3B
-53.11%8B
Net non-operating interest income (expenses)
61M
3,400.00%33M
644.44%49M
50.00%-1M
10.00%-9M
-2M
-50.00%-3M
0.00%-2M
33.33%-2M
9.09%-10M
Non-operating interest income
--72M
975.00%43M
862.50%77M
100.00%4M
14.29%8M
--2M
0.00%2M
0.00%2M
100.00%2M
16.67%7M
Non-operating interest expense
--11M
100.00%10M
64.71%28M
25.00%5M
0.00%17M
--4M
25.00%5M
0.00%4M
0.00%4M
0.00%17M
Net investment income
149M
40.75%373M
-59.71%166M
35.90%265M
-4.41%412M
7M
7.22%208M
-50.00%2M
-14.85%195M
20.06%431M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
0
99.67%-2M
-2,307.69%-287M
-605M
1,200.00%13M
9M
0
0.00%1M
Income from associates and other participating interests
Special income (charges)
27M
63.64%-12M
-745.21%-1.59B
10.81%-33M
90.29%-188M
-100M
-111.11%-19M
-700.00%-32M
88.54%-37M
47.05%-1.94B
Less:Other special charges
---27M
-63.64%12M
-40.24%101M
-10.81%33M
128.38%169M
--81M
111.11%19M
700.00%32M
94.74%37M
-88.86%74M
Less:Write off
----
----
7,731.58%1.49B
----
-98.98%19M
--19M
----
----
--0
-37.78%1.86B
Other non-operating income (expenses)
-1M
175.00%3M
10.53%63M
-300.00%-4M
-82.93%57M
25M
-65.91%15M
-78.26%15M
-95.92%2M
158.91%334M
Income before tax
587M
-82.75%409M
98.40%19.44B
-31.30%2.37B
43.70%9.8B
576M
-19.27%3.56B
-47.71%2.21B
-13.90%3.45B
-50.90%6.82B
Income tax
182M
-77.80%137M
210.17%5.49B
-34.36%617M
28.54%1.77B
-775M
-22.17%955M
-44.21%650M
-14.55%940M
-68.24%1.38B
Net income
406M
-84.55%271M
73.77%13.95B
-30.12%1.75B
47.52%8.03B
1.35B
-18.15%2.61B
-49.04%1.56B
-13.66%2.51B
-43.03%5.44B
Net income continuous operations
--405M
-84.49%272M
73.75%13.95B
-30.15%1.75B
47.54%8.03B
--1.35B
-18.15%2.61B
-49.05%1.56B
-13.65%2.51B
-43.03%5.44B
Noncontrolling interests
0
0
0
0
Net income attributable to the company
406M
-84.55%271M
73.77%13.95B
-30.12%1.75B
47.52%8.03B
1.35B
-18.15%2.61B
-49.04%1.56B
-13.66%2.51B
-43.03%5.44B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
406M
-84.55%271M
73.77%13.95B
-30.12%1.75B
47.52%8.03B
1.35B
-18.15%2.61B
-49.04%1.56B
-13.66%2.51B
-43.03%5.44B
Gross dividend payment
Basic earnings per share
10.71
-84.61%7.13
71.82%365.42
-30.86%46.32
46.87%212.67
35.57
-18.89%68.92
-49.42%41.19
-12.90%66.99
-42.41%144.8
Diluted earnings per share
10.71
-84.61%7.13
71.82%365.42
-30.86%46.32
46.87%212.67
35.57
-18.98%68.841
-49.42%41.19
-12.90%66.99
-42.41%144.8
Dividend per share
0
0
0.00%150
0
0.00%150
75
0
0.00%75
0
0.00%150
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023
Total revenue 18.26B3.36%18.87B30.52%94.04B0.57%18.25B-1.29%72.04B17.36B-1.28%18.51B-3.23%18.02B-0.26%18.15B-4.01%72.98B
Cost of revenue 9.01B9.67%9B5.96%35.5B1.33%8.2B0.23%33.51B8.68B-2.37%8.38B0.98%8.36B-0.77%8.09B-2.99%33.43B
Gross profit 9.25B-1.79%9.87B51.88%58.53B-0.04%10.05B-2.57%38.54B8.68B-0.34%10.14B-6.60%9.66B0.16%10.06B-4.86%39.56B
Operating expense 8.9B35.01%9.86B29.19%37.49B7.97%7.3B-8.02%29.02B8.04B13.17%6.78B20.18%7.44B13.02%6.76B28.75%31.55B
Staff costs --1.81B0.06%1.73B-0.17%7.11B-2.97%1.73B-0.99%7.12B--1.85B-1.34%1.76B-3.57%1.73B-0.94%1.78B-2.88%7.19B
Research and development costs --3.97B79.52%5.38B49.29%18.73B15.31%3B-20.56%12.54B--4.04B39.60%2.76B36.43%3.14B28.08%2.6B87.52%15.79B
Depreciation and amortization ---------14.51%271M----8.93%317M----------------12.79%291M
-Depreciation ---------14.51%271M----8.93%317M----------------12.79%291M
Other operating expenses --3.12B6.65%2.74B25.97%11.39B8.15%2.57B9.18%9.04B--1.83B1.30%2.25B22.65%2.58B10.50%2.38B-1.71%8.28B
Operating profit 351M-99.42%16M121.06%21.04B-16.48%2.75B18.93%9.52B641M-19.69%3.36B-46.54%2.22B-18.80%3.3B-53.11%8B
Net non-operating interest income (expenses) 61M3,400.00%33M644.44%49M50.00%-1M10.00%-9M-2M-50.00%-3M0.00%-2M33.33%-2M9.09%-10M
Non-operating interest income --72M975.00%43M862.50%77M100.00%4M14.29%8M--2M0.00%2M0.00%2M100.00%2M16.67%7M
Non-operating interest expense --11M100.00%10M64.71%28M25.00%5M0.00%17M--4M25.00%5M0.00%4M0.00%4M0.00%17M
Net investment income 149M40.75%373M-59.71%166M35.90%265M-4.41%412M7M7.22%208M-50.00%2M-14.85%195M20.06%431M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 099.67%-2M-2,307.69%-287M-605M1,200.00%13M9M00.00%1M
Income from associates and other participating interests
Special income (charges) 27M63.64%-12M-745.21%-1.59B10.81%-33M90.29%-188M-100M-111.11%-19M-700.00%-32M88.54%-37M47.05%-1.94B
Less:Other special charges ---27M-63.64%12M-40.24%101M-10.81%33M128.38%169M--81M111.11%19M700.00%32M94.74%37M-88.86%74M
Less:Write off --------7,731.58%1.49B-----98.98%19M--19M----------0-37.78%1.86B
Other non-operating income (expenses) -1M175.00%3M10.53%63M-300.00%-4M-82.93%57M25M-65.91%15M-78.26%15M-95.92%2M158.91%334M
Income before tax 587M-82.75%409M98.40%19.44B-31.30%2.37B43.70%9.8B576M-19.27%3.56B-47.71%2.21B-13.90%3.45B-50.90%6.82B
Income tax 182M-77.80%137M210.17%5.49B-34.36%617M28.54%1.77B-775M-22.17%955M-44.21%650M-14.55%940M-68.24%1.38B
Net income 406M-84.55%271M73.77%13.95B-30.12%1.75B47.52%8.03B1.35B-18.15%2.61B-49.04%1.56B-13.66%2.51B-43.03%5.44B
Net income continuous operations --405M-84.49%272M73.75%13.95B-30.15%1.75B47.54%8.03B--1.35B-18.15%2.61B-49.05%1.56B-13.65%2.51B-43.03%5.44B
Noncontrolling interests 0000
Net income attributable to the company 406M-84.55%271M73.77%13.95B-30.12%1.75B47.52%8.03B1.35B-18.15%2.61B-49.04%1.56B-13.66%2.51B-43.03%5.44B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 406M-84.55%271M73.77%13.95B-30.12%1.75B47.52%8.03B1.35B-18.15%2.61B-49.04%1.56B-13.66%2.51B-43.03%5.44B
Gross dividend payment
Basic earnings per share 10.71-84.61%7.1371.82%365.42-30.86%46.3246.87%212.6735.57-18.89%68.92-49.42%41.19-12.90%66.99-42.41%144.8
Diluted earnings per share 10.71-84.61%7.1371.82%365.42-30.86%46.3246.87%212.6735.57-18.98%68.841-49.42%41.19-12.90%66.99-42.41%144.8
Dividend per share 000.00%15000.00%1507500.00%7500.00%150
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The ceasefire between the US and Iran faces new uncertainties! According to the latest report by Axios, Trump will receive a briefing from t Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -